Neuralink, Elon Musk’s Brain Implant Startup, Receives FDA Approval for Human Study

Elon Musk’s Neuralink has obtained FDA approval for its first human clinical trial, marking a significant milestone for the brain-implant startup. The approval comes amidst ongoing investigations into Neuralink’s handling of animal experiments, where concerns were raised about rushed surgeries and improper implant sizing. Despite the scrutiny, Neuralink expressed its commitment to leveraging its technology to help many people. More details about the clinical trial will be available soon.

Brazilian Lawmakers File Complaint Against Google for Controversial ‘Slavery Simulator’ Game

A game titled “Simulador de Escravidão” or “Slavery Simulator” that allowed users to simulate the Atlantic slave trade in 17th century Brazil was available for download on Google Play for about a month. The game, which involved buying, selling, punishing, and sexualizing enslaved people, sparked outrage and led to complaints from Brazilian lawmakers and advocacy … Read more

Dr. Douglas Carlson Announces Retirement from MACOM Technology Solutions

Dr. Douglas Carlson, Senior Vice President of Technology at MACOM, has announced his retirement after a distinguished 33-year career. Recognized for his significant contributions to MACOM’s technological advancements, Dr. Carlson will transition to a role on the newly created Technical Advisory Committee. MACOM, a leading semiconductor supplier, expresses gratitude for his leadership and dedication.

Lazard Unveils New Leadership: Peter R. Orszag as CEO and Kenneth M. Jacobs as Executive Chairman

Peter R. Orszag, currently CEO of Financial Advisory at Lazard, has been unanimously elected by its Board to serve as CEO of Lazard and as a Board Director.

Kenneth M. Jacobs, Chairman and CEO of Lazard, will serve as Executive Chairman of the Board and will continue to advise clients on strategic financial matters.

These changes will take effect October 1, 2023.